[HTML][HTML] Distinct features of doublecortin as a marker of neuronal migration and its implications in cancer cell mobility

AA Ayanlaja, Y Xiong, Y Gao, GQ Ji, C Tang… - Frontiers in molecular …, 2017 - frontiersin.org
Neuronal migration is a critical process in the development of the nervous system. Defects in
the migration of the neurons are associated with diseases like lissencephaly, subcortical …

[HTML][HTML] Migration/invasion of malignant gliomas and implications for therapeutic treatment

CA Liu, CY Chang, KW Hsueh, HL Su… - International journal of …, 2018 - mdpi.com
Malignant tumors of the central nervous system (CNS) are among cancers with the poorest
prognosis, indicated by their association with tumors of high-level morbidity and mortality …

CD133 is essential for glioblastoma stem cell maintenance

P Brescia, B Ortensi, L Fornasari, D Levi, G Broggi… - Stem …, 2013 - academic.oup.com
The role of the cell surface CD133 as a cancer stem cell marker in glioblastoma (GBM) has
been widely investigated, since it identifies cells that are able to initiate neurosphere growth …

PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion

MC Caino, JC Ghosh, YC Chae… - Proceedings of the …, 2015 - National Acad Sciences
Molecular therapies are hallmarks of “personalized” medicine, but how tumors adapt to
these agents is not well-understood. Here we show that small-molecule inhibitors of …

[HTML][HTML] Preclinical evidence of STAT3 inhibitor pacritinib overcoming temozolomide resistance via downregulating miR-21-enriched exosomes from M2 glioblastoma …

HY Chuang, Y Su, HW Liu, CH Chen, SC Chiu… - Journal of Clinical …, 2019 - mdpi.com
Background: The tumor microenvironment (TME) plays a crucial role in virtually every aspect
of tumorigenesis of glioblastoma multiforme (GBM). A dysfunctional TME promotes drug …

LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response

S Faletti, D Osti, E Ceccacci, C Richichi… - Science Translational …, 2021 - science.org
Glioblastoma (GBM) is a fatal tumor whose aggressiveness, heterogeneity, poor blood-brain
barrier penetration, and resistance to therapy highlight the need for new targets and clinical …

[HTML][HTML] Cancer stem cell contribution to glioblastoma invasiveness

B Ortensi, M Setti, D Osti, G Pelicci - Stem cell research & therapy, 2013 - Springer
Glioblastoma (GBM) is the most aggressive and lethal brain tumor in adults. Its invasive
nature currently represents the most challenging hurdle to surgical resection. The …

Fabrication and characterization of chitosan–hyaluronic acid scaffolds with varying stiffness for glioblastoma cell culture

AE Erickson, SK Lan Levengood, J Sun… - Advanced …, 2018 - Wiley Online Library
The invasive and recurrent nature of glioblastoma multiforme (GBM) is linked to a small
subpopulation of cancer cells, which are self‐renewing, resistant to standard treatment …

CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas

V Gleize, A Alentorn, L Connen de Kérillis… - Annals of …, 2015 - Wiley Online Library
Objective CIC gene is frequently mutated in oligodendroglial tumors with 1p19q codeletion.
However, clinical and biological impact remain poorly understood. Methods We sequenced …

[HTML][HTML] Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth

M Setti, D Osti, C Richichi, B Ortensi, M Del Bene… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Little progresses have been made in the treatment of glioblastoma (GBM), the most
aggressive and lethal among brain tumors. Recently we have demonstrated that Chloride …